bicalutamide has been researched along with cyproterone in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (44.44) | 18.7374 |
1990's | 3 (33.33) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ackerman, JH; Bell, MR; Christiansen, RG; D'Ambra, TE; Herrmann, JL; Kullnig, RK; Mallamo, JP; Opalka, CJ; Snyder, BW; Winneker, RC | 1 |
Schröder, FH | 1 |
Mowszowicz, I | 1 |
Furr, BJ | 2 |
Daricello, G; Pavone, C; Pavone-Macaluso, M; Romano, C; Serretta, V | 1 |
Denis, L; Mahler, C; Verhelst, J | 1 |
Ahn, SC; Chatterjee, B; Lavrovsky, Y; Roy, AK; Song, CS; Tyagi, RK | 1 |
Cucalón, JM; Guiu, M | 1 |
3 review(s) available for bicalutamide and cyproterone
Article | Year |
---|---|
Pure antiandrogens as monotherapy in prospective studies of prostatic carcinoma.
Topics: Androgen Antagonists; Anilides; Animals; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Nitriles; Prospective Studies; Prostatic Neoplasms; Tosyl Compounds | 1990 |
[Antiandrogens. Mechanisms and paradoxical effects].
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgens; Anilides; Cimetidine; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Nitriles; Spironolactone; Tosyl Compounds | 1989 |
Clinical pharmacokinetics of the antiandrogens and their efficacy in prostate cancer.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Clinical Trials as Topic; Cyproterone; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 1998 |
1 trial(s) available for bicalutamide and cyproterone
Article | Year |
---|---|
Pure antiandrogens as monotherapy in prospective studies of prostatic carcinoma.
Topics: Androgen Antagonists; Anilides; Animals; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Nitriles; Prospective Studies; Prostatic Neoplasms; Tosyl Compounds | 1990 |
6 other study(ies) available for bicalutamide and cyproterone
Article | Year |
---|---|
Antiandrogenic steroidal sulfonylpyrazoles.
Topics: Androgen Antagonists; Animals; Male; Molecular Structure; Orchiectomy; Organ Size; Pregnanes; Prostate; Pyrazoles; Rats; Rats, Inbred Strains; Receptors, Androgen; Structure-Activity Relationship; Testosterone; X-Ray Diffraction | 1990 |
"Casodex" (ICI 176,334)--a new, pure, peripherally-selective anti-androgen: preclinical studies.
Topics: Androgen Antagonists; Anilides; Animals; Cyproterone; Cyproterone Acetate; Dogs; Flutamide; Imidazoles; Imidazolidines; Male; Nitriles; Prostatic Neoplasms; Rats; Tosyl Compounds | 1989 |
[Antiandrogens in monotherapy or combined therapy for treatment of advanced cancer of the prostate].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Flutamide; Follow-Up Studies; Humans; Imidazoles; Imidazolidines; Male; Middle Aged; Neoplasm Staging; Nitriles; Orchiectomy; Prostatic Neoplasms; Tosyl Compounds | 1989 |
ICI 176,334: a novel non-steroidal, peripherally-selective antiandrogen.
Topics: Androgen Antagonists; Anilides; Animals; Cyproterone; Cyproterone Acetate; Dogs; Flutamide; Imidazoles; Imidazolidines; Male; Nitriles; Prostate; Radioligand Assay; Rats; Receptors, Androgen; Seminal Vesicles; Testosterone; Tosyl Compounds | 1988 |
Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells.
Topics: Androgen Antagonists; Anilides; Animals; Biological Transport, Active; Cell Compartmentation; Cell Line; Cell Nucleus; Cyproterone; Cytoplasm; Dihydrotestosterone; Estradiol; Fatty Acids, Unsaturated; Green Fluorescent Proteins; Humans; Kinetics; Ligands; Luminescent Proteins; Nitriles; Progesterone; Rats; Receptors, Androgen; Recombinant Proteins; Tosyl Compounds; Transcriptional Activation | 2000 |
[The enigma of quaternary prevention in Primary Care. When and when not to do it (presentation of two cases)].
Topics: Aged, 80 and over; Androgen Antagonists; Anilides; Bone Density Conservation Agents; Cyproterone; Female; Humans; Inappropriate Prescribing; Indoles; Male; Nitriles; Osteoporosis; Primary Health Care; Prostatic Neoplasms; Tosyl Compounds | 2013 |